- CEO
- Raed Mohammed Abdullatif Al-Naeem
- Full Time Employees
- 700
- Sector
- Industrial services
- Industry
- Engineering & construction
- Address
- Building Number: 2529 Al Khobar Eastern Province Saudi Arabia 34434
- IPO Date
- Jan 10, 1999
- Business
- Ayyan Investment Company AYYAN Investment Co SJSC (2140.SR) is a Saudi joint-stock company headquartered in Al Khobar that invests in, establishes, and owns industrial projects, real estate, health, education, tourism, and agricultural facilities; it operates through three primary sectors including manufacturing, medical services, and investments. In the manufacturing sector, the company produces and packages dates and derivatives, establishes and operates cold storage facilities, and engages in wholesaling and retailing of food products through its wholly-owned subsidiary; it also holds stakes in paper manufacturing via Arab Paper Manufacturing Company (Waraq), where it reduced its ownership from 4.7% to 2.31% in 2024 following a partial sale and capital increase involving the Materials Recycling Company. The medical services sector focuses on establishing, maintaining, and operating hospitals, medical centers, and dispensaries, including a 25% stake in Tawariyat Medical Care Company, which secured Capital Market Authority approval for a direct listing on the parallel market in October 2024, and a 3.83% stake in Dallah Healthcare Company.
The investment sector encompasses ownership and management of real estate and lands, such as properties in Riyadh and Dammam via Rawasi Al Khaleej Real Estate Company formed in 2024; industrial investments like a 0.95% stake in Taqa Company for petroleum and petrochemical services; and other holdings in synthetic fibers, tourism via AHSANA Company, and securities. Founded in 1993 as Al Ahsa Development Company and renamed Ayyan Investment Company in July 2020, it conducts all operations within the Kingdom of Saudi Arabia. Recent major changes include the 2024 sale of all shares in subsidiaries Al Ahsa Medical Services Company and Al Salam Medical Services Company to Dallah Healthcare Company through a pioneering share purchase, subscription, and swap agreement advised by White & Case, resulting in Ayyan's 3.83% stake in Dallah; board recommendation in September 2025 to transfer SAR 59.8 million share premium to retained earnings; and Q1 2025 profit after prior losses, with manufacturing sales at SAR 15.44 million in 2024. The company maintains four subsidiaries and emphasizes maximizing asset value through strategic investments and quality management.